Jen Buist (Jennifer)

Jen (Jennifer) Buist has a diverse work experience in various industries. Jen (Jennifer) is currently working as the Director of Quality and Compliance at Medvantx since May 2022. Before that, they served as the Manager of Regulatory Compliance Audit Readiness at Centene Corporation from November 2019 to May 2022. Prior to that, they worked as the Manager of Compliance Reporting at Lumeris from January 2018 to November 2019. Jen also has experience working as the Senior Manager of Government Programs & Investigations at Express Scripts from February 2016 to December 2017. Jen (Jennifer) has worked as a Senior Data Analyst in Controlled Substances Compliance at Mallinckrodt Pharmaceuticals from December 2011 to February 2016. Before that, they served as an In-Process Quality Engineer II at Covidien from November 2007 to December 2011. Jen also has experience as an Owner at JMW Contract Services from November 2006 to February 2008, and as a Planner/Scheduler/ALM Interface at Pfizer from March 2007 to November 2007. Jen (Jennifer) has worked as a DEA Compliance Officer/Quality Assurance Manager at Legacy Pharmaceutical Packaging from April 2004 to November 2006, and as the Manager of Inventory & Purchasing at Fielding Pharmaceutical from 2000 to 2004. Overall, they have held positions of increasing responsibility and has expertise in quality and compliance management.

Jen Buist attended Washington University in St. Louis, although the exact start and end years of their education there are unknown. It is not specified what degree they pursued or what field of study they focused on during their time at the university.